Copyright Reports & Markets. All rights reserved.

Global Nuclear Radiation Therapeutic Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nuclear Radiation Therapeutic Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Diagnostic
    • 1.3.3 Therapeutic
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nuclear Radiation Therapeutic Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Oncology
    • 1.4.3 Thyroid
    • 1.4.4 Cardiology
    • 1.4.5 Others
  • 1.5 Global Nuclear Radiation Therapeutic Drugs Market Size & Forecast
    • 1.5.1 Global Nuclear Radiation Therapeutic Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Nuclear Radiation Therapeutic Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Nuclear Radiation Therapeutic Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Nihon Medi-Physics Co.,Ltd.
    • 2.1.1 Nihon Medi-Physics Co.,Ltd. Details
    • 2.1.2 Nihon Medi-Physics Co.,Ltd. Major Business
    • 2.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
  • 2.2 Curium Pharma
    • 2.2.1 Curium Pharma Details
    • 2.2.2 Curium Pharma Major Business
    • 2.2.3 Curium Pharma Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.2.4 Curium Pharma Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Curium Pharma Recent Developments/Updates
  • 2.3 Cardinal Health
    • 2.3.1 Cardinal Health Details
    • 2.3.2 Cardinal Health Major Business
    • 2.3.3 Cardinal Health Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.3.4 Cardinal Health Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Cardinal Health Recent Developments/Updates
  • 2.4 Bayer Global
    • 2.4.1 Bayer Global Details
    • 2.4.2 Bayer Global Major Business
    • 2.4.3 Bayer Global Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.4.4 Bayer Global Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bayer Global Recent Developments/Updates
  • 2.5 GE Healthcare
    • 2.5.1 GE Healthcare Details
    • 2.5.2 GE Healthcare Major Business
    • 2.5.3 GE Healthcare Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.5.4 GE Healthcare Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 GE Healthcare Recent Developments/Updates
  • 2.6 Mallinckrodt Pharmaceuticals
    • 2.6.1 Mallinckrodt Pharmaceuticals Details
    • 2.6.2 Mallinckrodt Pharmaceuticals Major Business
    • 2.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
  • 2.7 Bracco Group
    • 2.7.1 Bracco Group Details
    • 2.7.2 Bracco Group Major Business
    • 2.7.3 Bracco Group Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.7.4 Bracco Group Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bracco Group Recent Developments/Updates
  • 2.8 Advanced Molecular-imaging Solution
    • 2.8.1 Advanced Molecular-imaging Solution Details
    • 2.8.2 Advanced Molecular-imaging Solution Major Business
    • 2.8.3 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.8.4 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Advanced Molecular-imaging Solution Recent Developments/Updates
  • 2.9 Ciaeriar
    • 2.9.1 Ciaeriar Details
    • 2.9.2 Ciaeriar Major Business
    • 2.9.3 Ciaeriar Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.9.4 Ciaeriar Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Ciaeriar Recent Developments/Updates
  • 2.10 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
    • 2.10.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Details
    • 2.10.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
    • 2.10.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs Product and Services
    • 2.10.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates

3 Competitive Environment: Nuclear Radiation Therapeutic Drugs by Manufacturer

  • 3.1 Global Nuclear Radiation Therapeutic Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Nuclear Radiation Therapeutic Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Nuclear Radiation Therapeutic Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Nuclear Radiation Therapeutic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Nuclear Radiation Therapeutic Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Nuclear Radiation Therapeutic Drugs Manufacturer Market Share in 2025
  • 3.5 Nuclear Radiation Therapeutic Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Nuclear Radiation Therapeutic Drugs Market: Region Footprint
    • 3.5.2 Nuclear Radiation Therapeutic Drugs Market: Company Product Type Footprint
    • 3.5.3 Nuclear Radiation Therapeutic Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nuclear Radiation Therapeutic Drugs Market Size by Region
    • 4.1.1 Global Nuclear Radiation Therapeutic Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Nuclear Radiation Therapeutic Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Nuclear Radiation Therapeutic Drugs Average Price by Region (2021-2032)
  • 4.2 North America Nuclear Radiation Therapeutic Drugs Consumption Value (2021-2032)
  • 4.3 Europe Nuclear Radiation Therapeutic Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Nuclear Radiation Therapeutic Drugs Consumption Value (2021-2032)
  • 4.5 South America Nuclear Radiation Therapeutic Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Nuclear Radiation Therapeutic Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Nuclear Radiation Therapeutic Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Nuclear Radiation Therapeutic Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Nuclear Radiation Therapeutic Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Nuclear Radiation Therapeutic Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Nuclear Radiation Therapeutic Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Nuclear Radiation Therapeutic Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Nuclear Radiation Therapeutic Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Nuclear Radiation Therapeutic Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Nuclear Radiation Therapeutic Drugs Market Size by Country
    • 7.3.1 North America Nuclear Radiation Therapeutic Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Nuclear Radiation Therapeutic Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Nuclear Radiation Therapeutic Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Nuclear Radiation Therapeutic Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Nuclear Radiation Therapeutic Drugs Market Size by Country
    • 8.3.1 Europe Nuclear Radiation Therapeutic Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Nuclear Radiation Therapeutic Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nuclear Radiation Therapeutic Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Nuclear Radiation Therapeutic Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Nuclear Radiation Therapeutic Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Nuclear Radiation Therapeutic Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Nuclear Radiation Therapeutic Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Nuclear Radiation Therapeutic Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Nuclear Radiation Therapeutic Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Nuclear Radiation Therapeutic Drugs Market Size by Country
    • 10.3.1 South America Nuclear Radiation Therapeutic Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Nuclear Radiation Therapeutic Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nuclear Radiation Therapeutic Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Nuclear Radiation Therapeutic Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Nuclear Radiation Therapeutic Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Nuclear Radiation Therapeutic Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Nuclear Radiation Therapeutic Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Nuclear Radiation Therapeutic Drugs Market Drivers
  • 12.2 Nuclear Radiation Therapeutic Drugs Market Restraints
  • 12.3 Nuclear Radiation Therapeutic Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nuclear Radiation Therapeutic Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nuclear Radiation Therapeutic Drugs
  • 13.3 Nuclear Radiation Therapeutic Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nuclear Radiation Therapeutic Drugs Typical Distributors
  • 14.3 Nuclear Radiation Therapeutic Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nuclear Radiation Therapeutic Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Nuclear Radiation Therapeutic Drugs consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
    This report is a detailed and comprehensive analysis for global Nuclear Radiation Therapeutic Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Nuclear Radiation Therapeutic Drugs market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Nuclear Radiation Therapeutic Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Nuclear Radiation Therapeutic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Nuclear Radiation Therapeutic Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nuclear Radiation Therapeutic Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nuclear Radiation Therapeutic Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution, Ciaeriar, Shanghai Atom Kexing Pharmaceutical Co.,Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Nuclear Radiation Therapeutic Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Diagnostic
    Therapeutic
    Market segment by Application
    Oncology
    Thyroid
    Cardiology
    Others
    Major players covered
    Nihon Medi-Physics Co.,Ltd.
    Curium Pharma
    Cardinal Health
    Bayer Global
    GE Healthcare
    Mallinckrodt Pharmaceuticals
    Bracco Group
    Advanced Molecular-imaging Solution
    Ciaeriar
    Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nuclear Radiation Therapeutic Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nuclear Radiation Therapeutic Drugs, with price, sales quantity, revenue, and global market share of Nuclear Radiation Therapeutic Drugs from 2021 to 2026.
    Chapter 3, the Nuclear Radiation Therapeutic Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nuclear Radiation Therapeutic Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nuclear Radiation Therapeutic Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nuclear Radiation Therapeutic Drugs.
    Chapter 14 and 15, to describe Nuclear Radiation Therapeutic Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now